The impact of whole lung irradiation in lung metastatic rhabdomyosarcoma: A pooled analysis of two European trials and one European registry. [PDF]
Heinz AT +14 more
europepmc +1 more source
Metronomic (mCHT) vs standard (sCHT) chemotherapy as first-line treatment in HR+/HER2- Metastatic Breast Cancer (MBC) patients following failure of endocrine treatments. The matched control VICTOR-15 study. [PDF]
Cazzaniga ME +5 more
europepmc +1 more source
Unveiling Candidate Markers for Drug Resistance or Synthetic Lethality in Cervical Cancer: Integrative Analysis of Genetic and Pharmacoprofiling. [PDF]
Scholl S +10 more
europepmc +1 more source
Combination of Metronomic Chemotherapy and Rituximab in Frail and Elderly Patients with Relapsed/Refractory Follicular Lymphoma and Ineligible for Lenalidomide Treatment: A Retrospective Analysis. [PDF]
Pelliccia S +9 more
europepmc +1 more source
Beyond Acute EGFR Blockade: Biological Basis and Clinical Evidence for Long-Term Nimotuzumab Therapy. [PDF]
Crombet Ramos T +2 more
europepmc +1 more source
Sacituzumab govitecan in metastatic breast cancer: a systematic review and meta-analysis of its clinical benefit and safety. [PDF]
Wang Z, Lyu S, Mu Y, Pei X.
europepmc +1 more source
MOVIE phase II trial of tremelimumab plus durvalumab combined with metronomic oral vinorelbine in patients with head and neck cancer. [PDF]
Borcoman E +11 more
europepmc +1 more source
Melphalan-induced serpentine supravenous hyperpigmentation with associated venous thrombosis. [PDF]
Gueroum S +4 more
europepmc +1 more source
Related searches:

